title: Further evidence of the limitations of Activated Partial Thromboplastin Time to monitor Argatroban.
authors: Sheffield Thrombosis and Haemophilia Centre, Royal Hallamshire Hospital, Sheffield, UK.
authors: Susan
authors: S
authors: Guy
authors: Sheffield Thrombosis and Haemophilia Centre, Royal Hallamshire Hospital, Sheffield, UK.
authors: Steve
authors: S
authors: Kitchen
authors: Sheffield Thrombosis and Haemophilia Centre, Royal Hallamshire Hospital, Sheffield, UK.
authors: Joost J
authors: JJ
authors: Van Veen
mesh_terms: D001120:Arginine / Q000031:analogs & derivatives; D001777:Blood Coagulation / Q000187:drug effects*; D016903:Drug Monitoring / Q000379:methods; D006801:Humans; D010314:Partial Thromboplastin Time / Q000379:methods; D010875:Pipecolic Acids / Q000494:pharmacology* / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D013449:Sulfonamides
chemical_list: D010875:Pipecolic Acids; D010975:Platelet Aggregation Inhibitors; D013449:Sulfonamides; D001120:Arginine; C031942:argatroban
keywords: activated partial thromboplastin time; argatroban; direct thrombin inhibitor; heparin induced-thrombocytopenia